Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 11—November 2015
Letter

Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis

Cite This Article

To the Editor: Genotyping of Mycobacterium tuberculosis (MTB) has identified mixed infections involving >1 MTB strain (14), which are clinically relevant when different susceptibility patterns are involved (47). We describe a tuberculosis (TB) case-patient with mixed infection in an area of moderate incidence. In a low-resistance setting (monoresistance 4.6%; multiresistance 1.7%), 1 of the strains was drug susceptible and the other was multidrug-resistant (MDR). Molecular fingerprinting and epidemiologic research revealed that the infection corresponded to a recent infection by a susceptible strain and reactivation of an MDR TB strain. The patient was an HIV-negative woman, 47 years of age, who had immigrated to Spain from Romania and had been living in Almería for >3 years. TB was diagnosed in May 2014; she had experienced symptoms for 2 months. Her diagnosis was confirmed 3 years after being studied in Almería as a close contact of her husband, also from Romania, who had tested positive for MDR TB (resistant to rifampin and isoniazid). When she was observed in the contact trace, she tested positive for purified protein derivative, had been vaccinated against the M. bovis bacillus Calmette-Guérin strain, and had no radiologic findings or clinical symptoms. Based on the susceptibility profile of her husband, prophylaxis was not prescribed. Her husband adhered to anti-TB treatment for 20 months; all microbiological control test results had been negative since 2 months after starting therapy.

Figure

Thumbnail of Identification of co-infection with drug-susceptible and reactivated latent multidrug-resistant Mycobacterium tuberculosis (MDR TB).  A) Genotype of multidrug-resistant tuberculosis (MDR TB) and results for the MDR TB index patient and for 2 respiratory specimens and 1 cultured isolate from the case-patient who had a mixed MDR/susceptible infection. The same indeterminate intense-wt/faint mutant pattern test was repeated by using another 2 specimens. B) Mycobacterial interspersed re

Figure. Identification of co-infection with drug-susceptible and reactivated latent multidrug-resistant Mycobacterium tuberculosis (MDR TB). A) Genotype of multidrug-resistant tuberculosis (MDR TB) and results for the MDR TB index patient and for...

Because her infection was thought to originate from previous contact with an MDR TB case-patient, we assessed her sputum samples for resistance using GenoType-MTBDR-plus (Hain-Lifescience, Nehren, Rhineland-Paltinate, Germany). The test showed hybridization with the same mutant probes (rpoB-MUT3; katG-MUT1) as those of her husband, the assumed index MDR TB case-patient (Figure, panel A). The pattern was indeterminate because the hybridization for the mutant probes was faint, and intense hybridization was observed for all the wt probes (Figure, panel A). Results suggested the simultaneous presence of an MDR strain and a susceptible strain in a respiratory specimen. The presence of the MDR TB strain was confirmed by the phenotypic antibiogram in a BBL MGIT mycobacteria growth indicator tube (Becton Dickinson, Franklin Lakes, NJ, USA) after the isolate had been cultured. GeneXpert (Cepheid, Sunnyvale, CA, USA) was used to analyze 2 respiratory specimens. Results indicated susceptibility to rifampin, revealing the limitations of this test: the use of probes targeting the wt sequences failed to detect resistant strains that coexist with a susceptible strain (7).

To ascertain the likelihood of 2 co-infecting strains, we analyzed the specimen and the cultured isolate by mycobacterial interspersed repetitive unit–variable number tandem repeat (MIRU-VNTR), which is highly sensitive for detecting complex infections (8,9). Double alleles were found at 12 loci (Figure, panel B), confirming co-infection.

Peaks in the electropherograms suggested that 1 of the 2 strains was under-represented and its proportion was lower in the cultured isolates (Figure, panel C), indicating that culturing diminished its representation of the minority strain. This finding was consistent with the inability of the GenoType test to detect the MDR strain when applied to the cultured isolate (Figure, panel A). We also detected lower fitness for the MDR strain compared to the susceptible strain (p<0.01) (Technical Appendix Table).

Proportions of the resistant and susceptible strains were determined by plating on Middlebrook 7H11 +/− isoniazid (0.4 μL/mL) and counting single colonies. Because 2% of the colonies were of the resistant strain, we separated the strains and concluded: 1) the strain cultured in the presence of an antimicrobial drug coincided in the population exclusively with the MDR strain from the husband (as shown by MIRU-VNTR); and 2) the co-infecting MDR strain was a minority strain that was under-represented in the cultured isolate.

To analyze the origin of the susceptible strain, we investigated its MIRU-VNTR type in the population-based molecular epidemiology survey (10) and found another 4 cases (from 2008, 2011 [2 cases], and 2014). Three case-patients had emigrated from Romania, and all 5 case-patients lived in the same area of Almeria. These data indicated that the susceptible strain was circulating in the geographic/epidemiological context of the current case-patient before and when she tested positive for that strain; therefore, she likely acquired the susceptible strain through recent transmission.

The presence of susceptible and resistant strains in a patient should be considered even in moderate incidence settings and where resistance rates are not high. Underdetection of these cases could lead to misinterpretation when MDR became apparent after treatment of susceptible strains. Diagnostic laboratories could easily screen for mixed infections by applying MIRU-VNTR. However, only by integrating clonal analysis, refined molecular typing, and epidemiologic data from universal genotyping programs can we clarify the reasons underlying complex MTB infections. For this case-patient, a recent infection with a susceptible strain coincided with or could have triggered reactivation of a latent infection involving an MDR strain acquired through close contact years previously. We emphasize the alteration of the true clonal complexity of an infection induced by culturing specimens and that some commercial tests do not identify complex MTB infections. These findings are particularly relevant when the infection involves resistant strains such as those found in this case-patient.

Top

Acknowledgments

We thank Thomas O’Boyle for proofreading the manuscript.

This study was supported by Plan Estatal de I+D+I 2013-2016, ISCIII (PI 12/02080; 13/01207) and Fondo Europeo de Desarrollo Regional FEDER “Una manera de hacer Europa.”

Y.N. was supported by a PICATA predoctoral fellowship (BE55/11) from the Moncloa Campus of International Excellence (UCM-UPM, Instituto de Investigación Sanitaria Gregorio Marañón).

Top

Laura Pérez-Lago, Miguel Martínez Lirola, Yurena Navarro, Marta Herranz, María Jesús Ruiz-Serrano, Emilio Bouza, and Darío García-de-Viedma

Author affiliations: Gregorio Marañón University General Hospital, Madrid, Spain (L. Pérez-Lago, Y. Navarro, M. Herranz, M.J. Ruiz-Serrano, E. Bouza, D. García-de-Viedma); Gregorio Marañón Health Research Institute, Madrid (L. Pérez-Lago, Y. Navarro, M. Herranz, M.J. Ruiz-Serrano, E. Bouza, D. García-de-Viedma); Centro de Investigación Biomédica en Red en Enfermedades Respiratorias, Madrid (L. Pérez-Lago, Y. Navarro, M. Herranz, M.J. Ruiz-Serrano, E. Bouza, D. García-de-Viedma); Torrecárdenas Hospital, Almería, Spain (M. Martinez Lirola); Complutense University of Madrid, Spain (E. Bouza); Moncloa International Campus of Excellence, Complutense University-Politécnica University, Madrid (Y. Navarro, D. García-de-Viedma)

Top

References

  1. Warren  RM, Victor  TC, Streicher  EM, Richardson  M, Beyers  N, Gey van Pittius  NC, Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med. 2004;169:6104. DOIPubMed
  2. Shin  SS, Modongo  C, Ncube  R, Sepako  E, Klausner  JD, Zetola  NM. Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in Botswana. J Infect Dis. 2015;211:34751. DOIPubMed
  3. Dickman  KR, Nabyonga  L, Kateete  DP, Katabazi  FA, Asiimwe  BB, Mayanja  HK, Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala, Uganda. BMC Infect Dis. 2010;10:349. DOIPubMed
  4. Niemann  S, Richter  E, Rüsch-Gerdes  S, Schlaak  M, Greinert  U. Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis. Emerg Infect Dis. 2000;6:54851. DOIPubMed
  5. Hingley-Wilson  SM, Casey  R, Connell  D, Bremang  S, Evans  JT, Hawkey  PM, Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection. Emerg Infect Dis. 2013;19:113841. DOIPubMed
  6. Mendez  MP, Landon  ME, McCloud  MK, Davidson  P, Christensen  PJ. Co-infection with pansensitive and multidrug-resistant strains of Mycobacterium tuberculosis. Emerg Infect Dis. 2009;15:57880. DOIPubMed
  7. Zetola  NM, Shin  SS, Tumedi  KA, Moeti  K, Ncube  R, Nicol  M, Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. J Clin Microbiol. 2014;52:24229. DOIPubMed
  8. García de Viedma  D, Alonso Rodriguez  N, Andres  S, Ruiz Serrano  MJ, Bouza  E. Characterization of clonal complexity in tuberculosis by mycobacterial interspersed repetitive unit-variable-number tandem repeat typing. J Clin Microbiol. 2005;43:56604. DOIPubMed
  9. Supply  P, Lesjean  S, Savine  E, Kremer  K, van Soolingen  D, Locht  C. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol. 2001;39:356371. DOIPubMed
  10. Alonso-Rodriguez  N, Martinez-Lirola  M, Sanchez  ML, Herranz  M, Penafiel  T, Bonillo Mdel  C, Prospective universal application of mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping to characterize Mycobacterium tuberculosis isolates for fast identification of clustered and orphan cases. J Clin Microbiol. 2009;47:202632. DOIPubMed

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid2111.150683

Related Links

Top

Table of Contents – Volume 21, Number 11—November 2015

Page created: October 19, 2015
Page updated: October 19, 2015
Page reviewed: October 19, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external